KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Other Non-Current Liabilities (2016 - 2025)

Johnson & Johnson's Other Non-Current Liabilities history spans 17 years, with the latest figure at $10.3 billion for Q2 2025.

  • For Q2 2025, Other Non-Current Liabilities rose 722.36% year-over-year to $10.3 billion; the TTM value through Jun 2025 reached $10.3 billion, up 722.36%, while the annual FY2023 figure was $1.1 billion, 2.5% down from the prior year.
  • Other Non-Current Liabilities for Q2 2025 was $10.3 billion at Johnson & Johnson, up from $1.2 billion in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $10.3 billion in Q2 2025 and bottomed at $486.0 million in Q2 2022.
  • The 5-year median for Other Non-Current Liabilities is $1.1 billion (2023), against an average of $1.4 billion.
  • The largest annual shift saw Other Non-Current Liabilities crashed 63.09% in 2021 before it surged 722.36% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $613.0 million in 2021, then fell by 14.36% to $525.0 million in 2022, then soared by 108.0% to $1.1 billion in 2023, then increased by 11.9% to $1.2 billion in 2024, then skyrocketed by 739.85% to $10.3 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Other Non-Current Liabilities are $10.3 billion (Q2 2025), $1.2 billion (Q3 2024), and $1.2 billion (Q2 2024).